MGX — Metagenomi Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Metagenomi Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	108	362	271	248	161
Net Total Accounts Receivable
Net Total Receivables	0.49	1.95	2.45	1.26	0.305
Prepaid Expenses
Total Current Assets	109	367	278	258	166
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	21.9	33.3	65.2	57.7	47.4
Long Term Investments
Other Long Term Assets
Total Assets	142	414	365	325	221
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	25.2	48.5	68.9	37.3	22.9
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	98	143	150	89.7	62.5
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	44	272	215	235	159
Total Liabilities & Shareholders' Equity	142	414	365	325	221
Total Common Shares Outstanding
Total Preferred Shares Outstanding